🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of the study is to test if taking a study drug called emri...
Status
Terminated
Location
Indiana University
Start Date
2013-07
Trial ID
NCT01912404
To validate the ability of the Methacetin Breath Test (MBT) to detect clini...
Status
Completed
Location
Hopital Beaujon
Start Date
2016-08-28
Trial ID
NCT03439189
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled trial i...
Status
Completed
Location
Pasadena
Start Date
2016-10-17
Trial ID
NCT02960204
The purpose of this study is to determine the safety and efficacy of IDN-65...
Status
Completed
Location
University of Miami
Start Date
2014-03
Trial ID
NCT02077374
This is a multicenter study to see if treatment with IDN-6556 can help impr...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-08
Trial ID
NCT02230670
The study will evaluate the pharmacokinetics, pharmacodynamics, safety and ...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-09
Trial ID
NCT01937130
This is a double-blind, multicenter study involving patients with chronic H...
Status
Completed
Location
Southern California Research Center
Start Date
2014-05
Trial ID
NCT02138253
This is an open-label pilot study to evaluate the safety, tolerability, and...
Status
Completed
Location
VA Connecticut Healthcare System
Start Date
2014-08
Trial ID
NCT02230683
Treatments Being Tested
Treatments for COVID-19 are urgently needed. Emricasan (EMR) is a pan caspa...
Status
Terminated
Location
SUNY Downstate Health Sciences University
Start Date
2021-03-11
Trial ID
NCT04803227
This is a multicenter, double-blind, randomized, placebo-controlled study t...
Status
Unknown
Location
The Institute for Liver Health
Start Date
2017-06-28
Trial ID
NCT03205345
Treatments Being Tested